StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.06−0.44 (-12.57%)

Close on Nov 18, 2026Market cap $62.83KP/E –Yield –

Addex Therapeutics cash

Cash and short-term investments held at the end of each period.

Addex Therapeutics's cash was CHF 767.33K at Jun 30, 2026. For fiscal 2025 it was CHF 1.64M, down 51.0% from the year before. The highest annual figure on record is CHF 31.54M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025CHF 1.64M-51.0%
FY2024Dec 31, 2024CHF 3.34M-13.5%
FY2023Dec 31, 2023CHF 3.87M-44.4%
FY2022Dec 31, 2022CHF 6.96M-66.0%
FY2021Dec 31, 2021CHF 20.48M+9.6%
FY2020Dec 31, 2020CHF 18.70M-40.7%
FY2019Dec 31, 2019CHF 31.54M0.0%
FY2018Dec 31, 2018CHF 31.54M+1122.7%
FY2017Dec 31, 2017CHF 2.58M+82.9%
FY2016Dec 31, 2016CHF 1.41M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026CHF 767.33K-79.7%
Q4 FY2025Dec 31, 2025CHF 1.64M-57.6%
Q2 FY2025Jun 30, 2025CHF 2.30M-67.9%
Q4 FY2024Dec 31, 2024CHF 3.34M-52.0%
Q2 FY2024Jun 30, 2024CHF 3.79M-57.0%
Q4 FY2023Dec 31, 2023CHF 3.87M-81.1%
Q2 FY2023Jun 30, 2023CHF 7.17M-60.4%
Q4 FY2022Dec 31, 2022CHF 6.96M-62.8%
Q2 FY2022Jun 30, 2022CHF 8.81M-72.1%
Q4 FY2021Dec 31, 2021CHF 20.48M-35.0%
Q2 FY2021Jun 30, 2021CHF 18.11M+602.1%
Q4 FY2020Dec 31, 2020CHF 18.70M+1225.8%
Q4 FY2019Dec 31, 2019CHF 31.54M–
Q4 FY2018Dec 31, 2018CHF 31.54M–
Q4 FY2017Dec 31, 2017CHF 2.58M–
Q4 FY2016Dec 31, 2016CHF 1.41M–

More Addex Therapeutics figures

See a number that looks wrong?